Keywords: avalon, signs, 200m, merck, co, accord, usa

Avalon signs $200M Merck & Co R&D accord

Article | 12 March 2007

The USA's Avalon Pharmaceuticals has entered a drug discovery, development and commercialization collaboration with drug major Merck & Co focused on ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Drug Discovery

Go to company listing